Panwarfin - Drug Details
๐Ÿ“Š Estimates Panwarfin Dialyzability By Different_Modalities

Panwarfin

Complete Drug Information

Drug Name
Panwarfin
Trade Names
Coumadin
Pregnancy Category
AU: D
Bioavailability
79โ€“100% (by mouth)
Routes of Administration
Oral, intravenous
Protein Binding
99%%
Metabolism
Liver: CYP2C9, 2C19, 2C8, 2C18, 1A2 and 3A4
Elimination
7 days (active half-life is 20-60 hours)
Excretion
Kidney (92%)
Formula
C19H16O4
Molar Mass
308.333
Volume of Distribution
C19H16O4

๐Ÿคฐ Pregnancy Category Information

Category: AU: D

Drugs which have caused, are suspected to have caused, or may be expected to cause an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.